The trading price of Merck & Co Inc (NYSE:MRK) closed lower on Tuesday, April 02, closing at $130.35, -0.49% lower than its previous close.
The company’s P/E ratio in the trailing 12-month period was 986.01, while its 5Y monthly beta was 0.38. In examining the 52-week price action we see that the stock hit a 52-week high of $133.10 and a 52-week low of $99.14. Over the past month, the stock has gained 2.67% in value.
Merck & Co Inc, whose market valuation is $330.13 billion at the time of this writing, is expected to release its quarterly earnings report Apr 25, 2024. The dividend yield on the company stock is 2.30%, while its Forward Dividend ratio is 3.00. Investors’ optimism about the company’s current quarter earnings report is understandable.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Merck & Co Inc No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest MRK has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 14.59, which symbolizes a positive outlook. A quick review shows that MRK’s price is currently 4.77% off the SMA20 and 4.44% off the SMA50. The RSI metric on the 14-day chart is currently showing 67.08, and weekly volatility stands at 1.37%. When measured over the past 30 days, the indicator reaches 1.66%. Merck & Co Inc (NYSE:MRK)’s beta value is currently sitting at 0.40, while the Average True Range indicator is currently displaying 2.19.
To see how Merck & Co Inc stock has been performing in comparison to its peers in the industry, here are the numbers: MRK stock’s performance was -0.49% in the latest trading, and 23.06% in the past year. Merck & Co Inc has a P/E ratio of 986.01.
An evaluation of the daily trading volume of Merck & Co Inc (NYSE:MRK) indicates that the 3-month average is 8.75 million. However, this figure has increased over the past 10 days to an average of 9.14 million.
Currently, records show that 2.53 billion of the company’s shares remain outstanding. The insiders hold 0.15% of outstanding shares, whereas institutions hold 78.68%. The stats also highlight that short interest as of Mar 15, 2024, stood at 23.16 million shares, resulting in a short ratio of 2.41 at that time. From this, we can conclude that short interest is 0.91% of the company’s total outstanding shares. It is noteworthy that short shares in March were up slightly from the previous month’s figure, which was 16.82 million. However, since the stock’s price has seen 19.57% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
